1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Recombinant DNA Technology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Therapeutic Agent 1.2.3 Vaccine 1.2.4 Biotech Crops 1.2.5 Specialty Chemicals 1.3 Market by Application 1.3.1 Global Recombinant DNA Technology Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Biotechnology and Pharmaceutical Companies 1.3.3 Academic & Government Research Institutes 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Recombinant DNA Technology Market Perspective (2016-2027) 2.2 Recombinant DNA Technology Growth Trends by Regions 2.2.1 Recombinant DNA Technology Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Recombinant DNA Technology Historic Market Share by Regions (2016-2021) 2.2.3 Recombinant DNA Technology Forecasted Market Size by Regions (2022-2027) 2.3 Recombinant DNA Technology Industry Dynamic 2.3.1 Recombinant DNA Technology Market Trends 2.3.2 Recombinant DNA Technology Market Drivers 2.3.3 Recombinant DNA Technology Market Challenges 2.3.4 Recombinant DNA Technology Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Recombinant DNA Technology Players by Revenue 3.1.1 Global Top Recombinant DNA Technology Players by Revenue (2016-2021) 3.1.2 Global Recombinant DNA Technology Revenue Market Share by Players (2016-2021) 3.2 Global Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Recombinant DNA Technology Revenue 3.4 Global Recombinant DNA Technology Market Concentration Ratio 3.4.1 Global Recombinant DNA Technology Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Recombinant DNA Technology Revenue in 2020 3.5 Recombinant DNA Technology Key Players Head office and Area Served 3.6 Key Players Recombinant DNA Technology Product Solution and Service 3.7 Date of Enter into Recombinant DNA Technology Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Recombinant DNA Technology Breakdown Data by Type 4.1 Global Recombinant DNA Technology Historic Market Size by Type (2016-2021) 4.2 Global Recombinant DNA Technology Forecasted Market Size by Type (2022-2027) 5 Recombinant DNA Technology Breakdown Data by Application 5.1 Global Recombinant DNA Technology Historic Market Size by Application (2016-2021) 5.2 Global Recombinant DNA Technology Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Recombinant DNA Technology Market Size (2016-2027) 6.2 North America Recombinant DNA Technology Market Size by Type 6.2.1 North America Recombinant DNA Technology Market Size by Type (2016-2021) 6.2.2 North America Recombinant DNA Technology Market Size by Type (2022-2027) 6.2.3 North America Recombinant DNA Technology Market Size by Type (2016-2027) 6.3 North America Recombinant DNA Technology Market Size by Application 6.3.1 North America Recombinant DNA Technology Market Size by Application (2016-2021) 6.3.2 North America Recombinant DNA Technology Market Size by Application (2022-2027) 6.3.3 North America Recombinant DNA Technology Market Size by Application (2016-2027) 6.4 North America Recombinant DNA Technology Market Size by Country 6.4.1 North America Recombinant DNA Technology Market Size by Country (2016-2021) 6.4.2 North America Recombinant DNA Technology Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Recombinant DNA Technology Market Size (2016-2027) 7.2 Europe Recombinant DNA Technology Market Size by Type 7.2.1 Europe Recombinant DNA Technology Market Size by Type (2016-2021) 7.2.2 Europe Recombinant DNA Technology Market Size by Type (2022-2027) 7.2.3 Europe Recombinant DNA Technology Market Size by Type (2016-2027) 7.3 Europe Recombinant DNA Technology Market Size by Application 7.3.1 Europe Recombinant DNA Technology Market Size by Application (2016-2021) 7.3.2 Europe Recombinant DNA Technology Market Size by Application (2022-2027) 7.3.3 Europe Recombinant DNA Technology Market Size by Application (2016-2027) 7.4 Europe Recombinant DNA Technology Market Size by Country 7.4.1 Europe Recombinant DNA Technology Market Size by Country (2016-2021) 7.4.2 Europe Recombinant DNA Technology Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Recombinant DNA Technology Market Size (2016-2027) 8.2 Asia-Pacific Recombinant DNA Technology Market Size by Type 8.2.1 Asia-Pacific Recombinant DNA Technology Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Recombinant DNA Technology Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Recombinant DNA Technology Market Size by Type (2016-2027) 8.3 Asia-Pacific Recombinant DNA Technology Market Size by Application 8.3.1 Asia-Pacific Recombinant DNA Technology Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Recombinant DNA Technology Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Recombinant DNA Technology Market Size by Application (2016-2027) 8.4 Asia-Pacific Recombinant DNA Technology Market Size by Region 8.4.1 Asia-Pacific Recombinant DNA Technology Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Recombinant DNA Technology Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Recombinant DNA Technology Market Size (2016-2027) 9.2 Latin America Recombinant DNA Technology Market Size by Type 9.2.1 Latin America Recombinant DNA Technology Market Size by Type (2016-2021) 9.2.2 Latin America Recombinant DNA Technology Market Size by Type (2022-2027) 9.2.3 Latin America Recombinant DNA Technology Market Size by Type (2016-2027) 9.3 Latin America Recombinant DNA Technology Market Size by Application 9.3.1 Latin America Recombinant DNA Technology Market Size by Application (2016-2021) 9.3.2 Latin America Recombinant DNA Technology Market Size by Application (2022-2027) 9.3.3 Latin America Recombinant DNA Technology Market Size by Application (2016-2027) 9.4 Latin America Recombinant DNA Technology Market Size by Country 9.4.1 Latin America Recombinant DNA Technology Market Size by Country (2016-2021) 9.4.2 Latin America Recombinant DNA Technology Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Recombinant DNA Technology Market Size (2016-2027) 10.2 Middle East & Africa Recombinant DNA Technology Market Size by Type 10.2.1 Middle East & Africa Recombinant DNA Technology Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Recombinant DNA Technology Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Recombinant DNA Technology Market Size by Type (2016-2027) 10.3 Middle East & Africa Recombinant DNA Technology Market Size by Application 10.3.1 Middle East & Africa Recombinant DNA Technology Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Recombinant DNA Technology Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Recombinant DNA Technology Market Size by Application (2016-2027) 10.4 Middle East & Africa Recombinant DNA Technology Market Size by Country 10.4.1 Middle East & Africa Recombinant DNA Technology Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Recombinant DNA Technology Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Monsanto Company 11.1.1 Monsanto Company Company Details 11.1.2 Monsanto Company Business Overview 11.1.3 Monsanto Company Recombinant DNA Technology Introduction 11.1.4 Monsanto Company Revenue in Recombinant DNA Technology Business (2016-2021) 11.1.5 Monsanto Company Recent Development 11.2 Roche 11.2.1 Roche Company Details 11.2.2 Roche Business Overview 11.2.3 Roche Recombinant DNA Technology Introduction 11.2.4 Roche Revenue in Recombinant DNA Technology Business (2016-2021) 11.2.5 Roche Recent Development 11.3 Biogen 11.3.1 Biogen Company Details 11.3.2 Biogen Business Overview 11.3.3 Biogen Recombinant DNA Technology Introduction 11.3.4 Biogen Revenue in Recombinant DNA Technology Business (2016-2021) 11.3.5 Biogen Recent Development 11.4 Amgen 11.4.1 Amgen Company Details 11.4.2 Amgen Business Overview 11.4.3 Amgen Recombinant DNA Technology Introduction 11.4.4 Amgen Revenue in Recombinant DNA Technology Business (2016-2021) 11.4.5 Amgen Recent Development 11.5 Novartis 11.5.1 Novartis Company Details 11.5.2 Novartis Business Overview 11.5.3 Novartis Recombinant DNA Technology Introduction 11.5.4 Novartis Revenue in Recombinant DNA Technology Business (2016-2021) 11.5.5 Novartis Recent Development 11.6 Eli Lilly and Company 11.6.1 Eli Lilly and Company Company Details 11.6.2 Eli Lilly and Company Business Overview 11.6.3 Eli Lilly and Company Recombinant DNA Technology Introduction 11.6.4 Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2016-2021) 11.6.5 Eli Lilly and Company Recent Development 11.7 GenScript 11.7.1 GenScript Company Details 11.7.2 GenScript Business Overview 11.7.3 GenScript Recombinant DNA Technology Introduction 11.7.4 GenScript Revenue in Recombinant DNA Technology Business (2016-2021) 11.7.5 GenScript Recent Development 11.8 Pfizer Inc. 11.8.1 Pfizer Inc. Company Details 11.8.2 Pfizer Inc. Business Overview 11.8.3 Pfizer Inc. Recombinant DNA Technology Introduction 11.8.4 Pfizer Inc. Revenue in Recombinant DNA Technology Business (2016-2021) 11.8.5 Pfizer Inc. Recent Development 11.9 Novo Nordisk 11.9.1 Novo Nordisk Company Details 11.9.2 Novo Nordisk Business Overview 11.9.3 Novo Nordisk Recombinant DNA Technology Introduction 11.9.4 Novo Nordisk Revenue in Recombinant DNA Technology Business (2016-2021) 11.9.5 Novo Nordisk Recent Development 11.10 Sanofi 11.10.1 Sanofi Company Details 11.10.2 Sanofi Business Overview 11.10.3 Sanofi Recombinant DNA Technology Introduction 11.10.4 Sanofi Revenue in Recombinant DNA Technology Business (2016-2021) 11.10.5 Sanofi Recent Development 11.11 Merck KGaA 11.11.1 Merck KGaA Company Details 11.11.2 Merck KGaA Business Overview 11.11.3 Merck KGaA Recombinant DNA Technology Introduction 11.11.4 Merck KGaA Revenue in Recombinant DNA Technology Business (2016-2021) 11.11.5 Merck KGaA Recent Development 11.12 Profacgen 11.12.1 Profacgen Company Details 11.12.2 Profacgen Business Overview 11.12.3 Profacgen Recombinant DNA Technology Introduction 11.12.4 Profacgen Revenue in Recombinant DNA Technology Business (2016-2021) 11.12.5 Profacgen Recent Development 11.13 Biocon 11.13.1 Biocon Company Details 11.13.2 Biocon Business Overview 11.13.3 Biocon Recombinant DNA Technology Introduction 11.13.4 Biocon Revenue in Recombinant DNA Technology Business (2016-2021) 11.13.5 Biocon Recent Development 11.14 GlaxoSmithKline 11.14.1 GlaxoSmithKline Company Details 11.14.2 GlaxoSmithKline Business Overview 11.14.3 GlaxoSmithKline Recombinant DNA Technology Introduction 11.14.4 GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2016-2021) 11.14.5 GlaxoSmithKline Recent Development 11.15 Cibus 11.15.1 Cibus Company Details 11.15.2 Cibus Business Overview 11.15.3 Cibus Recombinant DNA Technology Introduction 11.15.4 Cibus Revenue in Recombinant DNA Technology Business (2016-2021) 11.15.5 Cibus Recent Development 11.16 Horizon Discovery Group 11.16.1 Horizon Discovery Group Company Details 11.16.2 Horizon Discovery Group Business Overview 11.16.3 Horizon Discovery Group Recombinant DNA Technology Introduction 11.16.4 Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2016-2021) 11.16.5 Horizon Discovery Group Recent Development 11.17 New England Biolabs 11.17.1 New England Biolabs Company Details 11.17.2 New England Biolabs Business Overview 11.17.3 New England Biolabs Recombinant DNA Technology Introduction 11.17.4 New England Biolabs Revenue in Recombinant DNA Technology Business (2016-2021) 11.17.5 New England Biolabs Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Recombinant DNA Technology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Therapeutic Agent Table 3. Key Players of Vaccine Table 4. Key Players of Biotech Crops Table 5. Key Players of Specialty Chemicals Table 6. Global Recombinant DNA Technology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Recombinant DNA Technology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Recombinant DNA Technology Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Recombinant DNA Technology Market Share by Regions (2016-2021) Table 10. Global Recombinant DNA Technology Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Recombinant DNA Technology Market Share by Regions (2022-2027) Table 12. Recombinant DNA Technology Market Trends Table 13. Recombinant DNA Technology Market Drivers Table 14. Recombinant DNA Technology Market Challenges Table 15. Recombinant DNA Technology Market Restraints Table 16. Global Recombinant DNA Technology Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Recombinant DNA Technology Market Share by Players (2016-2021) Table 18. Global Top Recombinant DNA Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant DNA Technology as of 2020) Table 19. Ranking of Global Top Recombinant DNA Technology Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Recombinant DNA Technology Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Recombinant DNA Technology Product Solution and Service Table 23. Date of Enter into Recombinant DNA Technology Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million) Table 26. Global Recombinant DNA Technology Revenue Market Share by Type (2016-2021) Table 27. Global Recombinant DNA Technology Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Recombinant DNA Technology Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Recombinant DNA Technology Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Recombinant DNA Technology Revenue Market Share by Application (2016-2021) Table 31. Global Recombinant DNA Technology Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Recombinant DNA Technology Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million) Table 34. North America Recombinant DNA Technology Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Recombinant DNA Technology Market Size by Application (2016-2021) (US$ Million) Table 36. North America Recombinant DNA Technology Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Recombinant DNA Technology Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Recombinant DNA Technology Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Recombinant DNA Technology Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Recombinant DNA Technology Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Recombinant DNA Technology Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Recombinant DNA Technology Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Recombinant DNA Technology Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Recombinant DNA Technology Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Recombinant DNA Technology Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Recombinant DNA Technology Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Recombinant DNA Technology Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Recombinant DNA Technology Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Recombinant DNA Technology Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Recombinant DNA Technology Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Recombinant DNA Technology Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Recombinant DNA Technology Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Recombinant DNA Technology Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Recombinant DNA Technology Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Recombinant DNA Technology Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Recombinant DNA Technology Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Recombinant DNA Technology Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Recombinant DNA Technology Market Size by Country (2022-2027) & (US$ Million) Table 63. Monsanto Company Company Details Table 64. Monsanto Company Business Overview Table 65. Monsanto Company Recombinant DNA Technology Product Table 66. Monsanto Company Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million) Table 67. Monsanto Company Recent Development Table 68. Roche Company Details Table 69. Roche Business Overview Table 70. Roche Recombinant DNA Technology Product Table 71. Roche Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million) Table 72. Roche Recent Development Table 73. Biogen Company Details Table 74. Biogen Business Overview Table 75. Biogen Recombinant DNA Technology Product Table 76. Biogen Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million) Table 77. Biogen Recent Development Table 78. Amgen Company Details Table 79. Amgen Business Overview Table 80. Amgen Recombinant DNA Technology Product Table 81. Amgen Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million) Table 82. Amgen Recent Development Table 83. Novartis Company Details Table 84. Novartis Business Overview Table 85. Novartis Recombinant DNA Technology Product Table 86. Novartis Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million) Table 87. Novartis Recent Development Table 88. Eli Lilly and Company Company Details Table 89. Eli Lilly and Company Business Overview Table 90. Eli Lilly and Company Recombinant DNA Technology Product Table 91. Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million) Table 92. Eli Lilly and Company Recent Development Table 93. GenScript Company Details Table 94. GenScript Business Overview Table 95. GenScript Recombinant DNA Technology Product Table 96. GenScript Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million) Table 97. GenScript Recent Development Table 98. Pfizer Inc. Company Details Table 99. Pfizer Inc. Business Overview Table 100. Pfizer Inc. Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million) Table 101. Pfizer Inc. Recent Development Table 102. Novo Nordisk Company Details Table 103. Novo Nordisk Business Overview Table 104. Novo Nordisk Recombinant DNA Technology Product Table 105. Novo Nordisk Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million) Table 106. Novo Nordisk Recent Development Table 107. Sanofi Company Details Table 108. Sanofi Business Overview Table 109. Sanofi Recombinant DNA Technology Product Table 110. Sanofi Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million) Table 111. Sanofi Recent Development Table 112. Merck KGaA Company Details Table 113. Merck KGaA Business Overview Table 114. Merck KGaA Recombinant DNA Technology Product Table 115. Merck KGaA Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million) Table 116. Merck KGaA Recent Development Table 117. Profacgen Company Details Table 118. Profacgen Business Overview Table 119. Profacgen Recombinant DNA Technology Product Table 120. Profacgen Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million) Table 121. Profacgen Recent Development Table 122. Biocon Company Details Table 123. Biocon Business Overview Table 124. Biocon Recombinant DNA Technology Product Table 125. Biocon Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million) Table 126. Biocon Recent Development Table 127. GlaxoSmithKline Company Details Table 128. GlaxoSmithKline Business Overview Table 129. GlaxoSmithKline Recombinant DNA Technology Product Table 130. GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million) Table 131. GlaxoSmithKline Recent Development Table 132. Cibus Company Details Table 133. Cibus Business Overview Table 134. Cibus Recombinant DNA Technology Product Table 135. Cibus Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million) Table 136. Cibus Recent Development Table 137. Horizon Discovery Group Company Details Table 138. Horizon Discovery Group Business Overview Table 139. Horizon Discovery Group Recombinant DNA Technology Product Table 140. Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million) Table 141. Horizon Discovery Group Recent Development Table 142. New England Biolabs Company Details Table 143. New England Biolabs Business Overview Table 144. New England Biolabs Recombinant DNA Technology Product Table 145. New England Biolabs Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million) Table 146. New England Biolabs Recent Development Table 147. Research Programs/Design for This Report Table 148. Key Data Information from Secondary Sources Table 149. Key Data Information from Primary Sources List of Figures Figure 1. Global Recombinant DNA Technology Market Share by Type: 2020 VS 2027 Figure 2. Therapeutic Agent Features Figure 3. Vaccine Features Figure 4. Biotech Crops Features Figure 5. Specialty Chemicals Features Figure 6. Global Recombinant DNA Technology Market Share by Application: 2020 VS 2027 Figure 7. Biotechnology and Pharmaceutical Companies Case Studies Figure 8. Academic & Government Research Institutes Case Studies Figure 9. Others Case Studies Figure 10. Recombinant DNA Technology Report Years Considered Figure 11. Global Recombinant DNA Technology Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Recombinant DNA Technology Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Recombinant DNA Technology Market Share by Regions: 2020 VS 2027 Figure 14. Global Recombinant DNA Technology Market Share by Regions (2022-2027) Figure 15. Global Recombinant DNA Technology Market Share by Players in 2020 Figure 16. Global Top Recombinant DNA Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant DNA Technology as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Recombinant DNA Technology Revenue in 2020 Figure 18. Global Recombinant DNA Technology Revenue Market Share by Type (2016-2021) Figure 19. Global Recombinant DNA Technology Revenue Market Share by Type (2022-2027) Figure 20. North America Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Recombinant DNA Technology Market Share by Type (2016-2027) Figure 22. North America Recombinant DNA Technology Market Share by Application (2016-2027) Figure 23. North America Recombinant DNA Technology Market Share by Country (2016-2027) Figure 24. United States Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Recombinant DNA Technology Market Share by Type (2016-2027) Figure 28. Europe Recombinant DNA Technology Market Share by Application (2016-2027) Figure 29. Europe Recombinant DNA Technology Market Share by Country (2016-2027) Figure 30. Germany Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Recombinant DNA Technology Market Share by Type (2016-2027) Figure 38. Asia-Pacific Recombinant DNA Technology Market Share by Application (2016-2027) Figure 39. Asia-Pacific Recombinant DNA Technology Market Share by Region (2016-2027) Figure 40. China Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Recombinant DNA Technology Market Share by Type (2016-2027) Figure 48. Latin America Recombinant DNA Technology Market Share by Application (2016-2027) Figure 49. Latin America Recombinant DNA Technology Market Share by Country (2016-2027) Figure 50. Mexico Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Recombinant DNA Technology Market Share by Type (2016-2027) Figure 54. Middle East & Africa Recombinant DNA Technology Market Share by Application (2016-2027) Figure 55. Middle East & Africa Recombinant DNA Technology Market Share by Country (2016-2027) Figure 56. Turkey Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Monsanto Company Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021) Figure 60. Roche Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021) Figure 61. Biogen Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021) Figure 62. Amgen Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021) Figure 63. Novartis Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021) Figure 64. Eli Lilly and Company Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021) Figure 65. GenScript Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021) Figure 66. Pfizer Inc. Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021) Figure 67. Novo Nordisk Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021) Figure 68. Sanofi Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021) Figure 69. Merck KGaA Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021) Figure 70. Profacgen Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021) Figure 71. Biocon Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021) Figure 72. GlaxoSmithKline Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021) Figure 73. Cibus Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021) Figure 74. Horizon Discovery Group Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021) Figure 75. New England Biolabs Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021) Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Monsanto Company Roche Biogen Amgen Novartis Eli Lilly and Company GenScript Pfizer Inc. Novo Nordisk Sanofi Merck KGaA Profacgen Biocon GlaxoSmithKline Cibus Horizon Discovery Group New England Biolabs